Search
Returning search results with filters:
Remove filter for
Last updated: 2020
Remove filter for
Type: Health professional risk communication
Clear all
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 15 of 28 items.
Authorization of Moderna COVID-19 Vaccine with English-only Vial and Carton Labels
Starting date:
December 23, 2020
Posting date:
December 23, 2020
Type of communication:
Dear…
AlertHealth professional risk communication | 2020-12-23
Bacitracin for Injection (50,000 IU per vial) and the Risk of Nephrotoxicity and Anaphylactic Reactions
Starting date:
December 21, 2020
Posting date:
December 21, 2020
Type…
AlertHealth professional risk communication | 2020-12-21
Authorization of Bamlanivimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
Starting date:
December 18, 2020
Posting date:
December 18, 2020
Type of…
AlertHealth professional risk communication | 2020-12-18
ELMIRON (pentosan polysulfate sodium) and the Risk of Pigmentary Maculopathy
Starting date:
December 15, 2020
Posting date:
December 15, 2020
Type of communication:
Dear…
AlertHealth professional risk communication | 2020-12-15
Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels
Starting date:
December 12, 2020
Posting date:
December 12, 2020
Type of…
AlertHealth professional risk communication | 2020-12-12
Importation of US-labelled Dexrazoxane for Injection distributed by Mylan Pharmaceuticals ULC due to shortage of Canadian-labelled Dexrazoxane
Starting date:
December 1, 2020…
AlertHealth professional risk communication | 2020-12-01
PICATO (ingenol mebutate gel, 0.015% and 0.05%) - Product Withdrawal in Canada due to Potential Increased Risk of Skin Cancer
Starting date:
October 27, 2020
Posting date:…
AlertHealth professional risk communication | 2020-10-27
Benzocaine-Containing Products and the Risk of Methemoglobinemia in Children under Two Years of Age
Starting date:
October 22, 2020
Posting date:
October 22, 2020
Type of…
AlertHealth professional risk communication | 2020-10-22
FIBRISTAL (ulipristal acetate tablets, 5 mg) - Voluntary Withdrawal in Canada due to Risk of Drug-Induced Liver Injury
Starting date:
September 30, 2020
Posting date:…
AlertHealth professional risk communication | 2020-09-30
Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir
Starting date:
September 8, 2020
Posting date:
September 15…
AlertHealth professional risk communication | 2020-09-15
ESBRIET (pirfenidone) and the Risk of Drug-Induced Liver Injury
Starting date:
September 14, 2020
Posting date:
September 14, 2020
Type of communication:
Dear Healthcare…
AlertHealth professional risk communication | 2020-09-14
Prescription Cough and Cold Products Containing Opioids and the Risk of Opioid Use Disorder in Children and Adolescents (< 18 years of age)
Starting date:
August 24, 2020…
AlertHealth professional risk communication | 2020-08-24
Methadone Treatment of Opioid Dependence and Potential Risk of Lack of Effect when Switching between Different Products
Starting date:
July 17, 2020
Posting date:
July 17,…
AlertHealth professional risk communication | 2020-07-17
NARDIL (phenelzine sulfate) Shortage
Starting date:
June 24, 2020
Posting date:
June 24, 2020
Type of communication:
Dear Healthcare Professional Letter
Subcategory:
Drugs…
AlertHealth professional risk communication | 2020-06-24
MabCampath (alemtuzumab) - Risk of Haemophagocytic Lymphohistiocytosis, Stroke (including ischaemic and haemorrhagic stroke), and Glomerulonephritis
Starting date:
June 22,…
AlertHealth professional risk communication | 2020-06-22